Citation: regazzoli, d.Md et al.Valve in a rigid mitral annuloplasty ring optimized by post-dilatation.Jacc: cardiovascular interventions.(2017) 10(19):e177-e179.Doi: 10.1016/j.Jcin.2017.07.043 earliest date of e-publish/publish used for event date. no unique device identifier (serial/lot) numbers were provided; without this information, it cannot be determined whether this event has been previously reported.If information is provided in the future, a supplemental report will be issued.
|
Medtronic received information via literature regarding a (b)(6) male patient with hypertension, non¿insulin-dependent diabetes, dyslipidemia, previous smoking with chronic obstructive pulmonary disease, and paroxysmal atrial fibrillation.Approximately three years prior, the patient had been implanted with a medtronic profile 3d 28mm annuloplasty ring.Serial number was not provided.A transesophageal echocardiogram (tee) indicated severe mitral regurgitation due to residual severe leaflet tethering, severe left ventricle dysfunction and moderate-to-severe pulmonary hypertension.Subsequently, a non-medtronic valve was implanted, valve in ring.No additional adverse patient effects or product performance issues were reported.
|